Speakers:
• Dr. Peter Piot, Professor, London School of Hygiene & Tropical Medicine; Senior Advisor, Gates Foundation; Independent Director Biocon Biologics and Biological E.
• Mr. Vikrant Shrotriya, MD, Novo Nordisk India
• Mr. Giuliano Perfetti, CEO & MD, Jubilant Biosys Limited
• Mr. Srinath Venkatesh, MD, India and South Asia, Thermo Fisher Scientific
• Mr. Amit Mookim, CEO, Immuneel Therapeutics Private Limited
• Mr. Hari Buggana, Founder & Chairman, Invascent
Moderator: Mr. Suresh Subramanian, Partner and National Life Sciences Leader, EY
Disclaimer—This is a raw, verbatim transcription of the discussion generated using AI and automated transcription tools. It may contain minor inaccuracies, grammatical inconsistencies, misinterpretations, or incomplete sentences. It should not be considered a fully edited or final record and should not be treated as an official verbatim transcript for publication or citation purposes.
